Assessment and post-treatment evaluation of absence epilepsy seizures

Not Applicable

Completed

• Conditions: Epilepsy; Nervous System Diseases; Petit mal status epilepticus

• Registration Number: ISRCTN45514614
• Lead Sponsor: ancaster University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-05-10
• Study Completion: 2019-09-30
• Last Update Posted: 10 December 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 2

Inclusion Criteria

1. Subjects eligible for inclusion in the experimental group for this study are children suspected of having absence seizures between the ages of 3- to 12-years
2. Subjects eligible for inclusion into the clinical control group are patients of a similar age, referred to Preston for a routine EEG, but not suspected of having absence seizures. If a patient is initially included in the experimental group but gets diagnosed with another condition other than absence seizures, they will be placed in the clinical control group
3. A further non-clinical control group, also age matched, will be collected at Lancaster University

Exclusion Criteria

1. Confounding medication use:
1.1. Ritalin
1.2. Antidepressants
1.3. Neuroleptic medications
1.4. Anti-epileptics
2. Significant learning difficulties, e.g. autism
3. Neurological conditions, e.g. cerebral palsy
4. The CI may judge a participant unable to take part in the non-clinical control group if they have a diagnosis of any neurological disorders

Study & Design

• Study Type: Interventional
• Study Design: Not specified